Effects of interferon alpha on myeloma cells: Mechanisms of differential responsiveness

Current Topics in Microbiology and Immunology

Volumn 224, Issue , 1997, Pages 261-268

  Jelinek, D F ^a   Arora, T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; RECOMBINANT ALPHA INTERFERON;

CELL GROWTH; CELL LABELING; CELL PROLIFERATION; CONFERENCE PAPER; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0030748959     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-60801-8_27     Document Type: Conference Paper

References (9)

1. Kyle RA (1995) Monoclonal gammopathy of undetermined significance (MGUS). Baillier's Clin Haematol 8:761-781
2. Kyle RA (1993) "Benign" monoclonal gammopathy - after 20 to 35 years of follow-up. Mayo Clinic Proc 68:26-36
3. Kyle RA, Lust JA (1989) Monoclonal gammopathies of undetermined significance. Semin Hematol 26:176-200
4. 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood 81:3382-3387
5. 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. Blood 72:219-223
6. Mellstedt HA, Ahre A, Bjorkholm M, Holm G, Johansson B, Strander H (1979) Interferon therapy in myelomatosis. Lancet 1:245-247
7. Oken MM (1994) Standard treatment of multiple myeloma. Mayo Clin Proc 69:781-786
8. Browman GP, Bergsagel D, Sicheri D, O'Reilly S, Wilson KS, Rubin S, Belch A, Shustik C, Barr R, Walker I, James K, Zee B, Johnston D (1995) Randomized trial of interferon maintenance in multiple myeloma: A study of the National Cancer Institute of Canada clinical trials group. J Clin Oncol 13:2354-2360
9. Ludwig H, Cohen AM, Polliack A, Huber H, Nachbaur D, Senn H-J, Morant R, Eckhardt S, Günczler P, Seewann HL, Schüller J, Rhyner K, Cavalli F, Fritz E (1995) Interferon-alpha for induction and maintenance in multiple myeloma: Results of two multicenter randomized trials and summary of other studies. Annals of Oncol 6:467-476